Lymph Node Imaging in Gynecologic Malignancy

Pecorelli, 2009, Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium, Int J Gynecol Obstet, 105, 103, 10.1016/j.ijgo.2009.02.012 Hertel, 2002, Laparoscopic staging compared with imaging techniques in the staging of advanced cervical cancer, Gynecol Oncol, 87, 46, 10.1006/gyno.2002.6722 Schlaerth, 2002, Laparoscopic retroperitoneal lymphadenectomy followed by immediate laparotomy in women with cervical cancer: A gynecologic oncology group study, Gynecol Oncol, 85, 81, 10.1006/gyno.2001.6555 Franchi, 2001, Postoperative complications after pelvic lymphadenectomy for the surgical staging of endometrial cancer, J Surg Oncol, 78, 232, 10.1002/jso.1158 Bidus, 2007, Cervical and vaginal cancers Fuller, 1989, Determinants of increased risk for recurrence in patients undergoing radical hysterectomy for stage IB and IIA carcinoma of the cervix, Gynecol Oncol, 33, 34, 10.1016/0090-8258(89)90598-2 Tsai, 1999, The prognostic factors for patients with early cervical cancer treated by radical hysterectomy and postoperative radiotherapy, Gynecol Oncol, 75, 328, 10.1006/gyno.1999.5527 Chan, 2007, The impact of the absolute number and ratio of positive lymph nodes on survival of endometrioid uterine cancer patients, Br J Cancer, 97, 605, 10.1038/sj.bjc.6603898 Watari, 2005, Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer, Gynecol Oncol, 96, 651, 10.1016/j.ygyno.2004.11.026 Ghurani, 2001, An update of vulvar cancer, Am J Obstet Gynecol, 185, 294, 10.1067/mob.2001.117401 Landoni, 1997, Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer, Lancet, 350, 535, 10.1016/S0140-6736(97)02250-2 Fiorica, 1990, Morbidity and survival patterns in patients after radical hysterectomy and postoperative adjuvant pelvic radiotherapy, Gynecol Oncol, 36, 343, 10.1016/0090-8258(90)90139-C Taylor, 2005, Mapping pelvic lymph nodes: Guidelines for delineation in intensity-modulated radiotherapy, Int J Radiat Oncol Biol Phys, 63, 1604, 10.1016/j.ijrobp.2005.05.062 Manfredi, 2004, Local-regional staging of endometrial carcinoma: Role of MR imaging in surgical planning, Radiology, 231, 372, 10.1148/radiol.2312021184 Schwartz, 2009, Evaluation of lymph nodes with RECIST. 1.1, Eur J Cancer, 45, 261, 10.1016/j.ejca.2008.10.028 Ferenschild, 2009, Total pelvic exenteration for primary and recurrent malignancies, World J Surg, 33, 1502, 10.1007/s00268-009-0066-7 Steinkamp, 1995, Cervical lymphadenopathy: Ratio of long-to short-axis diameter as a predictor of malignancy, Br J Radiol, 68, 266, 10.1259/0007-1285-68-807-266 Land, 2006, Routine computerized tomography scanning, groin ultrasound with or without fine needle aspiration cytology in the surgical management of primary squamous cell carcinoma of the vulva, Int J Gynecol Cancer, 16, 312, 10.1111/j.1525-1438.2006.00340.x Ahuja, 2003, Sonography of neck lymph nodes, Clin Radiol, 58, 359, 10.1016/S0009-9260(02)00585-8 Moskovic, 1999, The role of high resolution ultrasound with guided cytology of groin lymph nodes in the management of squamous cell carcinoma of the vulva: A pilot study, Br J Obstet Gynaecol, 106, 863, 10.1111/j.1471-0528.1999.tb08411.x Esen, 2006, Ultrasound of superficial lymph nodes, Eur J Radiol, 58, 345, 10.1016/j.ejrad.2005.12.039 Sohaib, 2003, Imaging in vulval cancer, Best Pract Res Clin Obstet Gynaecol, 17, 543, 10.1016/S1521-6934(03)00040-3 Hall, 2003, The role of ultrasound-guided cytology of groin lymph nodes in the management of squamous cell carcinoma of the vulva: 5-year experience in 44 patients, Clin Radiol, 58, 367, 10.1016/S0009-9260(02)00575-5 Glazer, 1985, Normal mediastinal lymph nodes: number and size according to American Thoracic Society mapping, AJR Am J Roentgenol, 144, 261, 10.2214/ajr.144.2.261 Vinnicombe, 1995, Normal pelvic lymph nodes: evaluation with CT after bipedal lymphangiography, Radiology, 194, 349, 10.1148/radiology.194.2.7824709 Magnusson, 1983, Size of normal retroperitoneal lymph nodes, Acta Radiol Diagn (Stockh), 24, 315, 10.1177/028418518302400407 Hricak, 1996, Radiology in invasive cervical cancer, AJR Am J Roentgenol, 167, 1101, 10.2214/ajr.167.5.8911159 Kitajima, 2008, Accuracy of 18F-FDG PET/CT in detecting pelvic and paraaortic lymph node metastasis in patients with endometrial cancer, AJR Am J Roentgenol, 190, 1652, 10.2214/AJR.07.3372 Benedetti-Panici, 1996, Lymphatic spread of cervical cancer: An anatomical and pathological study based on 225 radical hysterectomies with systematic pelvic and aortic lymphadenectomy, Gynecol Oncol, 62, 19, 10.1006/gyno.1996.0184 Jager, 1996, Pelvic adenopathy in prostatic and urinary bladder carcinoma: MR imaging with a three-dimensional TI-weighted magnetization-prepared-rapid gradient-echo sequence, AJR Am J Roentgenol, 167, 1503, 10.2214/ajr.167.6.8956585 Burke, 1996, Intraabdominal lymphatic mapping to direct selective pelvic and paraaortic lymphadenectomy in women with high-risk endometrial cancer: Results of a pilot study, Gynecol Oncol, 62, 169, 10.1006/gyno.1996.0211 McMeekin, 2001, Nodal distribution and its significance in FIGO stage IIIc endometrial cancer, Gynecol Oncol, 82, 375, 10.1006/gyno.2001.6278 Brown, 2003, Morphologic predictors of lymph node status in rectal cancer with use of high-spatial-resolution MR imaging with histopathologic comparison, Radiology, 227, 371, 10.1148/radiol.2272011747 van den Brekel, 1990, Detection and characterization of metastatic cervical adenopathy by MR imaging: Comparison of different MR techniques, J Comput Assist Tomogr, 14, 581, 10.1097/00004728-199007000-00014 Yang, 2000, Comparison of dynamic helical CT and dynamic MR imaging in the evaluation of pelvic lymph nodes in cervical carcinoma, AJR Am J Roentgenol, 175, 759, 10.2214/ajr.175.3.1750759 Yousem, 1992, Central nodal necrosis and extracapsular neoplastic spread in cervical lymph nodes: MR imaging versus CT, Radiology, 182, 753, 10.1148/radiology.182.3.1535890 van den Brekel, 1990, Cervical lymph node metastasis: Assessment of radiologic criteria, Radiology, 177, 379, 10.1148/radiology.177.2.2217772 Mitchell, 1986, Serous carcinoma of the ovary: CT identification of metastatic calcified implants, Radiology, 158, 649, 10.1148/radiology.158.3.3945732 Patel, 1999, Supradiaphragmatic manifestations of papillary serous adenocarcinoma of the ovary, Clin Radiol, 54, 748, 10.1016/S0009-9260(99)91178-9 Kim, 1994, Uterine cervical carcinoma: Evaluation of pelvic lymph node metastasis with MR imaging, Radiology, 190, 807, 10.1148/radiology.190.3.8115631 Yamada, 2009, Colorectal carcinoma: Local tumor staging and assessment of lymph node metastasis by high-Resolution MR imaging in surgical specimens, Int J Biomed Imaging, 10.1155/2009/659836 Dooms, 1985, Characterization of lymphadenopathy by magnetic resonance relaxation times: Preliminary results, Radiology, 155, 691, 10.1148/radiology.155.3.4001371 Vaupel, 1994 Barentsz, 1996, Staging urinary bladder cancer after transurethral biopsy: Value of fast dynamic contrast-enhanced MR imaging, Radiology, 201, 185, 10.1148/radiology.201.1.8816542 Kinkel, 1997, Differentiation between recurrent tumor and benign conditions after treatment of gynecologic pelvic carcinoma: Value of dynamic contrast-enhanced subtraction MR imaging, Radiology, 204, 55, 10.1148/radiology.204.1.9205223 Fischbein, 2003, Assessment of metastatic cervical adenopathy using dynamic contrast-enhanced MR imaging, AJNR Am J Neuroradiol, 24, 301 Laissy, 1994, Enlarged mediastinal lymph nodes in bronchogenic carcinoma: Assessment with dynamic contrast-enhanced MR imaging, Radiology, 191, 263, 10.1148/radiology.191.1.8134585 Rowley, 1999, Imaging, Neuroimaging Clin N Am, 9, 343 Lin, 2008, Detection of lymph node metastasis in cervical and uterine cancers by diffusion-weighted magnetic resonance imaging at 3T, J Magn Reson Imaging, 28, 128, 10.1002/jmri.21412 Ross, 2003, Evaluation of cancer therapy using diffusion magnetic resonance imaging, Mol Cancer Ther, 2, 581 Charles-Edwards, 2006, Diffusion-weighted magnetic resonance imaging and its application to cancer, Cancer Imaging, 6, 135, 10.1102/1470-7330.2006.0021 Colagrande, 2006, Magnetic resonance diffusion-weighted imaging: Extraneurological applications, Radiol Med, 111, 392, 10.1007/s11547-006-0037-0 Namimoto, 1997, Focal liver masses: Characterization with diffusion-weighted echo-planar MR imaging, Radiology, 204, 739, 10.1148/radiology.204.3.9280252 Naganawa, 2005, Apparent diffusion coefficient in cervical cancer of the uterus: Comparison with the normal uterine cervix, Eur Radiol, 15, 71, 10.1007/s00330-004-2529-4 Abdel Razek, 2006, Role of diffusion-weighted MR imaging in cervical lymphadenopathy, Eur Radiol, 16, 1468, 10.1007/s00330-005-0133-x Nakai, 2008, Detection and evaluation of pelvic lymph nodes in patients with gynecologic malignancies using body diffusion-weighted magnetic resonance imaging, J Comput Assist Tomogr, 32, 764, 10.1097/RCT.0b013e318153fd43 Ichikawa, 2006, High-B-value diffusion-weighted MRI in colorectal cancer, AJR Am J Roentgenol, 187, 181, 10.2214/AJR.05.1005 Kim, 2008, Feasibility of diffusion-weighted imaging in the differentiation of metastatic from nonmetastatic lymph nodes: early experience, J Magn Reson Imaging, 28, 714, 10.1002/jmri.21480 Weissleder, 1990, Ultrasmall superparamagnetic iron oxide: An intravenous contrast agent for assessing lymph nodes with MR imaging, Radiology, 175, 494, 10.1148/radiology.175.2.2326475 Koh, 2004, Rectal cancer: mesorectal lymph nodes at MR imaging with USPIO versus histopathologic findings—initial observations, Radiology, 231, 91, 10.1148/radiol.2311030142 Narayanan, 2009, Pearls and pitfalls of MR lymphography in gynecologic malignancy, Radiographics, 29, 1057, 10.1148/rg.294085231 Saksena, 2006, Comparison of lymphotropic nanoparticle-enhanced MRI sequences in patients with various primary cancers, AJR Am J Roentgenol, 187, W582, 10.2214/AJR.05.0873 Thoeny, 2009, Combined ultrasmall superparamagnetic particles of iron oxide-enhanced and diffusion-weighted magnetic resonance imaging reliably detect pelvic lymph node metastases in normal-sized nodes of bladder and prostate cancer patients, Eur Urol, 55, 761, 10.1016/j.eururo.2008.12.034 Sironi, 2006, Lymph node metastasis in patients with clinical early-stage cervical cancer: Detection with integrated FDG PET/CT, Radiology, 238, 272, 10.1148/radiol.2381041799 Reinhardt, 2001, Metastatic lymph nodes in patients with cervical cancer: Detection with MR imaging and FDG PET, Radiology, 218, 776, 10.1148/radiology.218.3.r01mr19776 Choi, 2006, Comparison of the accuracy of magnetic resonance imaging and positron emission tomography/computed tomography in the presurgical detection of lymph node metastases in patients with uterine cervical carcinoma: A prospective study, Cancer, 106, 914, 10.1002/cncr.21641 Amit, 2006, The role of hybrid PET/CT in the evaluation of patients with cervical cancer, Gynecol Oncol, 100, 65, 10.1016/j.ygyno.2005.07.013 Loft, 2007, The diagnostic value of PET/CT scanning in patients with cervical cancer: A prospective study, Gynecol Oncol, 106, 29, 10.1016/j.ygyno.2007.03.027 Bipat, 2003, Computed tomography and magnetic resonance imaging in staging of uterine cervical carcinoma: A systematic review, Gynecol Oncol, 91, 59, 10.1016/S0090-8258(03)00409-8 Kitajima, 2009, Accuracy of integrated FDG-PET/contrast-enhanced CT in detecting pelvic and paraaortic lymph node metastasis in patients with uterine cancer, Eur Radiol, 19, 1529, 10.1007/s00330-008-1271-8 Bristow, 2005, Combined PET/CT for detecting recurrent ovarian cancer limited to retroperitoneal lymph nodes, Gynecol Oncol, 99, 294, 10.1016/j.ygyno.2005.06.019 Fanti, 2006, Supra-clavicular lymph node metastatic spread in patients with ovarian cancer disclosed at 18F-FDG-PET/CT: An unusual finding, Cancer Imaging, 6, 20, 10.1102/1470-7330.2006.0005 Gontier, 2006, 18F-FDG PET/CT in a patient with lymph node metastasis from ovarian adenocarcinoma, AJR Am J Roentgenol, 187, W285, 10.2214/AJR.05.1483 Shreve, 1999, Pitfalls in oncologic diagnosis with FDG PET imaging: Physiologic and benign variants, Radiographics, 19, 61, 10.1148/radiographics.19.1.g99ja0761 Strauss, 1996, Fluorine-18 deoxyglucose and false-positive results: A major problem in the diagnostics of oncological patients, Eur J Nucl Med, 23, 1409, 10.1007/BF01367602 Bhargava, 2004, Iatrogenic artifacts on whole-body F-18 FDG PET imaging, Clin Nucl Med, 29, 429, 10.1097/01.rlu.0000129124.52554.92 Goerres, 2003, Artifacts at PET and PET/CT caused by metallic hip prosthetic material, Radiology, 226, 577, 10.1148/radiol.2262012141 Nakamoto, 2004, Artifacts caused by bowel motion, Nucl Med Commun, 25, 221, 10.1097/00006231-200403000-00002 Rennen, 2001, New concepts in infection/inflammation imaging, Q J Nucl Med, 45, 167 Veit, 2006, Lymph node staging with dual-modality PET/CT: Enhancing the diagnostic accuracy in oncology, Eur J Radiol, 58, 383, 10.1016/j.ejrad.2005.12.042 Kostakoglu, 2003, Clinical role of FDG PET in evaluation of cancer patients, Radiographics, 23, 315, 10.1148/rg.232025705 Schinagl, 2009, Can FDG-PET assist in radiotherapy target volume definition of metastatic lymph nodes in head-and-neck cancer?, Radiother Oncol, 91, 95, 10.1016/j.radonc.2009.02.007 Amant, 2005, Endometrial carcinosarcomas have a different prognosis and pattern of spread compared to high-risk epithelial endometrial cancer, Gynecol Oncol, 98, 274, 10.1016/j.ygyno.2005.04.027 Torne, 2004, The use of sentinel lymph nodes in gynaecological malignancies, Curr Opin Obstet Gynecol, 16, 57, 10.1097/00001703-200402000-00011 van der Zee, 2008, Sentinel node dissection is safe in the treatment of early-stage vulvar cancer, J Clin Oncol, 26, 884, 10.1200/JCO.2007.14.0566 Schneider, 2007, The sentinel concept in patients with cervical cancer, J Surg Oncol, 96, 337, 10.1002/jso.20864 Sakuragi, 2007, Up-to-date management of lymph node metastasis and the role of tailored lymphadenectomy in cervical cancer, Int J Clin Oncol, 12, 165, 10.1007/s10147-007-0661-2 Selman, 2008, A systematic review of tests for lymph node status in primary endometrial cancer, BMC Womens Health, 8, 8, 10.1186/1472-6874-8-8 Adib, 2006, The sentinel lymph node: Relevance in gynaecological cancers, Eur J Surg Oncol, 32, 866, 10.1016/j.ejso.2006.03.039 Barwick, 2009, Molecular PET and PET/CT imaging of tumour cell proliferation using F-18 fluoro-L-thymidine: A comprehensive evaluation, Nucl Med Commun, 30, 908, 10.1097/MNM.0b013e32832ee93b Tsujikawa, 2008, Uterine tumors: Pathophysiologic imaging with 16alpha-[18F]fluoro-17beta-estradiol and 18F fluorodeoxyglucose PET—initial experience, Radiology, 248, 599, 10.1148/radiol.2482071379 Wunderbaldinger, 2006, Optical imaging of lymph nodes, Eur J Radiol, 58, 390, 10.1016/j.ejrad.2005.12.043 Kim, 2009, Additional value of MR/PET fusion compared with PET/CT in the detection of lymph node metastases in cervical cancer patients, Eur J Cancer, 45, 2103, 10.1016/j.ejca.2009.04.006 von Schulthess, 2009, A look ahead: PET/MR versus PET/CT, Eur J Nucl Med Mol Imaging, 36, S3, 10.1007/s00259-008-0940-9 Carrington, 2004, Lymph node metastases Williams, 2001, Detection of pelvic lymph node metastases in gynecologic malignancy: A comparison of CT, MR imaging, and positron emission tomography, AJR Am J Roentgenol, 177, 343, 10.2214/ajr.177.2.1770343 Connor, 2000, Computed tomography in endometrial carcinoma, Obstet Gynecol, 95, 692, 10.1016/S0029-7844(99)00626-2 Zerbe, 2000, Inability of preoperative computed tomography scans to accurately predict the extent of myometrial invasion and extracorporeal spread in endometrial cancer, Gynecol Oncol, 78, 67, 10.1006/gyno.2000.5820 Inubashiri, 2009, Positron emission tomography with the glucose analog [F]-fluoro-2-deoxy-d-glucose for evaluating pelvic lymph node metastasis in uterine corpus cancer: Comparison with CT and MRI findings, J Obstet Gynaecol Res, 35, 26, 10.1111/j.1447-0756.2008.00832.x Tempany, 2000, Staging of advanced ovarian cancer: Comparison of imaging modalities—report from the Radiological Diagnostic Oncology Group, Radiology, 215, 761, 10.1148/radiology.215.3.r00jn25761 Ricke, 2003, Prospective evaluation of contrast-enhanced MRI in the depiction of peritoneal spread in primary or recurrent ovarian cancer, Eur Radiol, 13, 943, 10.1007/s00330-002-1712-8 Harisinghani, 2003, Noninvasive detection of clinically occult lymph-node metastases in prostate cancer, N Engl J Med, 348, 2491, 10.1056/NEJMoa022749 Rockall, 2005, Diagnostic performance of nanoparticle-enhanced magnetic resonance imaging in the diagnosis of lymph node metastases in patients with endometrial and cervical cancer, J Clin Oncol, 23, 2813, 10.1200/JCO.2005.07.166 Will, 2006, Diagnostic precision of nanoparticle-enhanced MRI for lymph-node metastases: A meta-analysis, Lancet Oncol, 7, 52, 10.1016/S1470-2045(05)70537-4